Used in pharmaceutical research as a key intermediate in the synthesis of selective sigma receptor ligands, particularly targeting sigma-1 and sigma-2 receptors. These receptors are implicated in neurological and psychiatric disorders, making the compound valuable in developing potential treatments for conditions such as neuropathic pain, depression, and neurodegenerative diseases. It also serves as a structural analog in medicinal chemistry for optimizing drug candidates with improved binding affinity and metabolic stability.